Loading...
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors.
Gargano, Emanuele M Perspicace, Enrico Hanke, Nina Carotti, Angelo Marchais-Oberwinkler, Sandrine Hartmann, Rolf W
Gargano, Emanuele M
Perspicace, Enrico
Hanke, Nina
Carotti, Angelo
Marchais-Oberwinkler, Sandrine
Hartmann, Rolf W
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2014-11-24
Submitted date
Files
Other Titles
Abstract
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational strategy to overcome the metabolic liability in the 2,5-thiophene amide class of 17β-HSD2 inhibitors is described, and the biological activity of the new inhibitors. Applying different strategies, as lowering the cLogP or modifying the structures of the molecules, compounds 27, 31 and 35 with strongly improved metabolic stability were obtained. For understanding biotransformation in the 2,5-thiophene amide class the main metabolic pathways of three properly selected compounds were elucidated.
Citation
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors. 2014, 87:203-19 Eur J Med Chem
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1768-3254